Medical and Pharma Insider’s Post

MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders The company is utilizing cutting-edge technologies to develop therapies with the goal of developing disease modifying therapies that are highly specific, efficacious, and safe. MedNews is a service of Medical and Pharma Insider, an FC Global Strategies company Medical and Pharma Insider website: https://lnkd.in/gtZtsJFe FC Global Strategies website: https://lnkd.in/gw9Phwm8 https://wix.to/K8OnZhd #revir #revirtherapeutics #cns #ai #mednews #medicalandpharmainsider

Medical and Pharma Insider

Medical and Pharma Insider

fcglobalstrategies.com

To view or add a comment, sign in

Explore topics